The landscape of CAR T-cell therapies is rapidly evolving but faces challenges due to a limited number of qualified cell therapy sites. These sites are often far from patient communities, creating barriers for patient access and slowing clinical trial progress. Featured in Applied Clinical Trials Magazine, Vito Romita explores strategies to overcome these challenges and extend the reach of life-transforming therapies. 📥 ➠ https://bit.ly/3AG0aHX
PPD
Research Services
Wilmington, NC 587,514 followers
Helping deliver life-changing therapies
About us
PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
- Website
-
https://www.ppd.com
External link for PPD
- Industry
- Research Services
- Company size
- 10,001+ employees
- Headquarters
- Wilmington, NC
- Type
- Public Company
- Specialties
- clinical research, drug development, CRO, patient recruitment, laboratory, pharmaceutical, biotechnology, biopharma, biopharmaceutical, consulting, therapeutics, Functional Service Partnerships, consulting, Early Development, Post-Approval, medical writing, drug information, pharmacovigilance, biostatistics, and bioanalytical
Locations
Employees at PPD
Updates
-
Join us for this upcoming sarcopenia webinar as we delve into the world of GLP-1 receptor agonist-based weight loss therapies. Our experts – Graham Ellis and Nathan, Ming-Yu Liu, along with Donna Ryan, Professor Emerita at Pennington Biomedical in Baton Rouge, Louisiana – will shed light on the changes and challenges in body composition with GLP-1 receptor agonist-based weight loss therapies. This is a unique opportunity to connect with industry leaders, enhance your knowledge and be part of a conversation driving scientific advancement. Don’t miss out, register today! » https://bit.ly/4cI3SOB
-
-
Are you attending #ESMO24? Stop by booth #522 to learn how our solutions can help you advance your #oncology #drugdevelopment with our full-spectrum, end-to-end solutions spanning from early drug discovery support and #clinicaldevelopment, through market access and commercial strategy. » https://bit.ly/3z2i8Un
-
-
📢 We are expanding our global footprint in Eastern Europe and West Asia 🌏 with our entry into the Republic of Georgia, and we're currently looking to hire Clinical Research Associates, Contract Specialists and Clinical Trial Coordinators. Register to join our online event on September 2 to learn more about #career opportunities with us. #LifeAtThermoFisher
This content isn’t available here
Access this content and more in the LinkedIn app
-
We are well positioned to overcome the challenges of lupus programs, including the complexities presented by promising CAR-T cell therapies. We're ready to leverage our proven strategies, experienced teams and specialized network of lupus sites to support your clinical trial. » https://bit.ly/3WVC7fp
-
-
To ensure medical products are safe and effective for all patient populations, there has been a concerted effort to foster #inclusivity in clinical research. Lloryn Hubbard offers her insights in Contract Pharma. » https://bit.ly/3YkwBFC
-
-
The shift in focus from symptom-control to disease-modifying treatments is defining the future of pulmonary arterial hypertension (PAH) #clinicaltrials. Our respiratory experts Francis Jones PhD, Michael Fitzula and Deena Richardson have complied an insightful analysis of this paradigm shift, presenting 7️⃣ key takeaways for success. See what the shift means for you. » https://bit.ly/3YRdALa #pulmonaryarterialhypertension #clinicaltrials #drugdevelopment
Shifting Paradigms in PAH Clinical Trials: 7 Key Takeaways
https://www.ppd.com
-
Speed is critical at every stage, yet R&D efficiency often remains evasive. Here’s how drug developers can overcome slowdowns to accelerate their studies. ⏱️
Infographic: Accelerate Clinical Research Timelines
https://www.ppd.com
-
Ever wondered about the intricate web of logistics behind #cellandgenetherapy #clinicaltrials? From sourcing specialized equipment to navigating regulatory requirements, every step is crucial in bringing innovative treatments to patients in need. We understand the nuances of these complex supply chains and have developed an end-to-end process to support your cell and gene therapy trial every step of the way. » https://bit.ly/3V8YOOd
-
-
Pharmacovigilance (PV) is crucial for drug and medical device development and commercialization. Effective PV regulatory intelligence (RI) is essential for accurate and cost-effective execution of PV. PV RI holds significance for all stakeholders in the industry. Learn more about the strategies deployed by increasing numbers of pharma, biotech and medical device companies to ensure comprehensive and cost-effective PV RI in our new white paper, which delves into the key PV RI capabilities drug developers should take note of, including: ➡️ Monitoring regulation changes ➡️ Analyzing and interpreting regulations and guidance ➡️ Communicating regulatory requirements, operationalizing change ➡️ Guiding concerning new and updated regulations ➡️ Functional service provider (FSP) partnerships 📥 » https://bit.ly/3yYRVWn
-